Using this technique, researchers identified LAMA2, MLL4, and PLXDC2 as novel serum biomarkers for prediabetes, with 0-20% higher specificity and 20-40% greater sensitivity than FBG and HbA1c (47). This evidence concerns the gene LAMA2 and prediabetes syndrome.